کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8476554 | 1550817 | 2018 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Bromodomain-containing proteins in prostate cancer
ترجمه فارسی عنوان
پروتئین حاوی برومودومین در سرطان پروستات
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
DDRHDACBRDNEPCNeuroendocrine prostate cancerBromodomain - برومودومینbromodomain and extra-terminal - برومودومین و اضافی ترمینالProstate cancer - سرطان پروستاتBET - شرطTranscription factor - عامل رونویسیTranscriptional co-activator - همکاری سازنده ترانزیتHistone acetyltransferase - هیستون استیل ترانسفرازhistone deacetylase - هیستون داستیلازDNA damage response - واکنش به آسیب DNA HAT - کلاهAndrogen Receptor - گیرنده آندروژنی
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
بیولوژی سلول
چکیده انگلیسی
Several oncogenic factors have been involved in prostate cancer progression. However, therapeutic approaches still focus on suppression of androgen receptor (AR) signaling. In fact, whereas the full-length AR incorporates a ligand-binding domain, which has become a drug target for competitive inhibitors, other transcription factors often do not have tractable binding pockets that aid drug development. Consequently drug development efforts have turned to transcription co-regulators, often chromatin-modifying enzymes or factors that bind to epigenetic modifications to chromatin. Bromodomain (BRD)-containing proteins fall into the latter category and significant progress has been made in developing small molecule inhibitors that target a particular subgroup of BRD-containing proteins known as the Bromodomain and extra-terminal (BET) family proteins. These inhibitors have proven particularly effective in inactivating c-Myc in lymphoma but more recently members of the BET family have also been identified as AR-interacting proteins raising the prospect of using these inhibitors as an alternative strategy for targeting AR-driven cancers. In this review we will provide an overview of BRD-containing proteins and the potential for exploiting them as biomarkers and drug targets in prostate cancer.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Molecular and Cellular Endocrinology - Volume 462, Part A, 15 February 2018, Pages 31-40
Journal: Molecular and Cellular Endocrinology - Volume 462, Part A, 15 February 2018, Pages 31-40
نویسندگان
Alfonso Urbanucci, Ian G. Mills,